TREAT Study - Improving the Interpretation of Troponin Concentrations Following Exercise and Their Clinical Significance

Active, not recruitingOBSERVATIONAL
Enrollment

1,015

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2044

Conditions
Coronary Artery Disease
Interventions
OTHER

Exercise exposure

"Exercise is NOT part of our study protocol. Participants will voluntarily participate in a mass-participation exercise event (i.e. walking, cycling or running). Participation in this exercise event is voluntary and independent from participation in this study (i.e. participants would also take part in the exercise event if they did not participate in our study). Therefore, we do not consider the performed exercise an intervention or part of our study protocol. Hence, we consider our study design to be observational.~Participants will perform exercise during a mass-participation exercise event, stratified for type of exercise (walking versus running versus cycling; n=500 each).~The mass-participation exercise events have a sport-specific minimum distance of:~a mass-participation exercise event with a:~* Walking distance ≥20 km~* Cycling distance ≥100 km~* Running distance ≥15 km"

Trial Locations (1)

6525 GC

RadboudUMC, Nijmegen

All Listed Sponsors
collaborator

Maastricht University Medical Center

OTHER

lead

Radboud University Medical Center

OTHER